Beta adrenergic blockers – Labetalol MCQs With Answer
This concise, student-focused introduction covers essential facts about labetalol — a mixed alpha-1 and nonselective beta adrenergic blocker widely used in hypertension, hypertensive emergencies, and pregnancy-induced hypertension. B. Pharm students will find clear points on mechanism of action, pharmacokinetics, dosing routes (oral and IV), adverse effects, contraindications, drug interactions, and monitoring requirements. These keyword-rich notes emphasize clinical relevance and pharmacology fundamentals to help you master exam-ready concepts and practical considerations in therapeutics. Now let’s test your knowledge with 50 MCQs on this topic.
Q1. Which best describes the pharmacologic classification of labetalol?
- A selective beta-1 adrenergic blocker
- A pure alpha-1 blocker
- A mixed alpha-1 and nonselective beta adrenergic blocker
- An alpha-2 agonist
Correct Answer: A mixed alpha-1 and nonselective beta adrenergic blocker
Q2. Labetalol is commonly used in which of the following clinical situations?
- Acute bronchospasm management
- Hypertensive emergency
- Severe bradyarrhythmias
- Uncontrolled asthma
Correct Answer: Hypertensive emergency
Q3. Which property of labetalol contributes to reduction in peripheral vascular resistance?
- Beta-2 agonism
- Alpha-1 blockade
- Beta-1 stimulation
- Monoamine oxidase inhibition
Correct Answer: Alpha-1 blockade
Q4. Labetalol’s effect on heart rate is primarily due to blockade of which receptor?
- Alpha-1 receptors
- Beta-1 receptors
- Beta-2 receptors
- Muscarinic receptors
Correct Answer: Beta-1 receptors
Q5. The recommended initial oral dose of labetalol for adults with hypertension is commonly:
- 10 mg once daily
- 100 mg twice daily
- 800 mg once daily
- 5 mg intravenously
Correct Answer: 100 mg twice daily
Q6. Which route of administration provides the most rapid onset of blood pressure lowering with labetalol?
- Oral tablets
- Intramuscular injection
- Intravenous infusion or bolus
- Transdermal patch
Correct Answer: Intravenous infusion or bolus
Q7. Which adverse effect is most likely due to labetalol’s beta-blocking activity?
- Nasal congestion
- Bronchospasm
- Hyperreflexia
- Polyuria
Correct Answer: Bronchospasm
Q8. Labetalol is often preferred in pregnancy for hypertension because:
- It is a teratogen in the first trimester
- It has a long half-life causing fetal accumulation
- It is effective and generally considered safe in pregnancy-induced hypertension
- It causes labor augmentation
Correct Answer: It is effective and generally considered safe in pregnancy-induced hypertension
Q9. Which of the following is a serious but rare adverse reaction associated with labetalol?
- Hepatotoxicity
- Excessive salivation
- Increased intraocular pressure
- Hyperkalemia
Correct Answer: Hepatotoxicity
Q10. Labetalol’s blockade of beta-2 receptors may cause which metabolic effect?
- Enhanced glycogenolysis masking hypoglycemia
- Increased insulin secretion
- Masking of hypoglycemic symptoms in diabetics
- Hyperglycemia due to beta-2 stimulation
Correct Answer: Masking of hypoglycemic symptoms in diabetics
Q11. Which of the following conditions is a contraindication to labetalol therapy?
- Controlled hypertension
- Asthma with active bronchospasm
- Migraine prophylaxis
- Essential tremor
Correct Answer: Asthma with active bronchospasm
Q12. Regarding intrinsic sympathomimetic activity (ISA), labetalol:
- Has significant ISA similar to pindolol
- Has partial agonist activity at beta receptors
- Does not exhibit clinically significant ISA
- Is a pure agonist at beta receptors
Correct Answer: Does not exhibit clinically significant ISA
Q13. Which monitoring parameter is most important when initiating labetalol therapy?
- Serum creatinine only
- Blood pressure and heart rate
- Peak expiratory flow only
- Serum sodium only
Correct Answer: Blood pressure and heart rate
Q14. The mechanism by which labetalol reduces blood pressure includes:
- Increasing cardiac contractility
- Vasodilation via alpha-1 blockade and decreased cardiac output via beta blockade
- Direct vasoconstriction
- Stimulation of renin release
Correct Answer: Vasodilation via alpha-1 blockade and decreased cardiac output via beta blockade
Q15. Which drug interaction is clinically important with labetalol?
- Combination with beta-2 agonists causing cancellation of effects
- Co-administration with digoxin increasing risk of bradycardia
- Labetalol increases theophylline levels dramatically
- Labetalol neutralizes ACE inhibitors
Correct Answer: Co-administration with digoxin increasing risk of bradycardia
Q16. For beta-blocker overdose including labetalol, which treatment is often used as an antidotal therapy?
- Glucagon
- Naloxone
- Flumazenil
- Atropine is contraindicated
Correct Answer: Glucagon
Q17. Labetalol’s bioavailability after oral administration is decreased mainly by:
- Renal excretion before absorption
- First-pass hepatic metabolism
- Binding to gastric acid
- Rapid pulmonary elimination
Correct Answer: First-pass hepatic metabolism
Q18. Which statement about labetalol and heart failure is correct?
- It is always safe in acute decompensated heart failure
- It is contraindicated in severe, decompensated heart failure
- It cures systolic dysfunction immediately
- It increases preload dramatically
Correct Answer: It is contraindicated in severe, decompensated heart failure
Q19. The typical onset of antihypertensive effect after an IV bolus of labetalol is approximately:
- 5 minutes
- 2 hours
- 24 hours
- 48 hours
Correct Answer: 5 minutes
Q20. Labetalol is metabolized primarily by which organ?
- Liver
- Kidney
- Skin
- Bone marrow
Correct Answer: Liver
Q21. When switching a patient from IV labetalol to oral therapy, which consideration is important?
- Oral dose must be drastically lower than IV dose
- Allow time for oral effect as IV wears off; monitor BP closely
- Oral labetalol has no antihypertensive effect
- No monitoring is required during transition
Correct Answer: Allow time for oral effect as IV wears off; monitor BP closely
Q22. Labetalol can exacerbate which of the following conditions due to beta-blockade?
- Hyperthyroidism symptom unmasking
- Peripheral vasodilation causing flushing
- Masking tachycardia in hypoglycemia
- Enhanced bronchodilation
Correct Answer: Masking tachycardia in hypoglycemia
Q23. Which laboratory test may be monitored periodically due to rare adverse effects of labetalol?
- Thyroid function tests
- Liver function tests (LFTs)
- Serum calcium
- Serum magnesium
Correct Answer: Liver function tests (LFTs)
Q24. Labetalol would be used cautiously with which class of antihypertensive because of additive negative chronotropic effects?
- Thiazide diuretics
- Calcium channel blockers like verapamil/diltiazem
- ACE inhibitors
- Potassium-sparing diuretics
Correct Answer: Calcium channel blockers like verapamil/diltiazem
Q25. Which statement about labetalol’s receptor selectivity is true?
- It selectively blocks beta-2 receptors only
- It is a nonselective beta-blocker with additional alpha-1 blockade
- It exclusively blocks alpha-2 receptors
- It blocks muscarinic receptors
Correct Answer: It is a nonselective beta-blocker with additional alpha-1 blockade
Q26. In pheochromocytoma management, labetalol is useful because it:
- Is a direct catecholamine agonist
- Provides both alpha and beta blockade to control blood pressure
- Increases catecholamine release
- Is contraindicated in pheochromocytoma
Correct Answer: Provides both alpha and beta blockade to control blood pressure
Q27. Which of the following is an advantage of labetalol over pure beta-blockers in hypertension?
- Greater bronchial selectivity
- Combined vasodilation and heart rate reduction improving BP control
- No risk of hypotension
- Increased cardiac output
Correct Answer: Combined vasodilation and heart rate reduction improving BP control
Q28. Labetalol is least likely to cause which side effect compared to pure beta-blockers?
- Bradycardia
- Peripheral vasoconstriction
- Bronchospasm
- Fatigue
Correct Answer: Peripheral vasoconstriction
Q29. Which patient should be closely monitored or avoid labetalol due to risk of bradycardia and heart block?
- Patient with second- or third-degree AV block
- Patient with controlled hypertension
- Patient with isolated systolic hypertension due to aging
- Patient with seasonal allergies
Correct Answer: Patient with second- or third-degree AV block
Q30. Labetalol may interact with clonidine; stopping clonidine abruptly while on labetalol can cause:
- Improved blood pressure control
- Severe rebound hypertension
- Immediate hypoglycemia
- Brisk diuresis
Correct Answer: Severe rebound hypertension
Q31. Which statement about labetalol’s chemical composition is correct?
- It is a racemic mixture with enantiomers contributing to alpha and beta activity
- It is a single enantiomer selective beta-1 blocker
- It is purely synthetic insulin analog
- It is a peptide hormone
Correct Answer: It is a racemic mixture with enantiomers contributing to alpha and beta activity
Q32. Labetalol’s duration of action after a single IV bolus is generally:
- Less than 5 minutes
- Approximately 2–4 hours
- 3–5 days
- Several weeks
Correct Answer: Approximately 2–4 hours
Q33. Which clinical sign would most directly suggest excessive beta-blockade from labetalol?
- Tachycardia and hypertension
- Bradycardia and hypotension
- Hyperreflexia and tremor
- Polyuria and polydipsia
Correct Answer: Bradycardia and hypotension
Q34. Labetalol’s effect on renin secretion is typically to:
- Increase renin release via beta-1 blockade
- Decrease renin release by blocking beta-1 receptors on juxtaglomerular cells
- Have no impact on renin
- Activate RAAS dramatically
Correct Answer: Decrease renin release by blocking beta-1 receptors on juxtaglomerular cells
Q35. Which patient counseling point is appropriate when starting oral labetalol?
- Expect immediate relief of symptoms within minutes of tablet
- Avoid sudden standing to reduce risk of orthostatic dizziness
- Discontinue abruptly if you feel dizzy
- It will significantly increase your exercise tolerance immediately
Correct Answer: Avoid sudden standing to reduce risk of orthostatic dizziness
Q36. Which antihypertensive combination with labetalol requires caution due to additive hypotension?
- Concurrent use with topical beta-2 agonists
- Concurrent use with nitrates or other vasodilators
- Concurrent use with levothyroxine
- Concurrent use with metformin
Correct Answer: Concurrent use with nitrates or other vasodilators
Q37. Labetalol may mask symptoms of which endocrine emergency due to its pharmacologic effects?
- Thyroid storm
- Hypoglycemia
- Cushing’s syndrome
- Hyperaldosteronism
Correct Answer: Hypoglycemia
Q38. In patients with peripheral vascular disease, labetalol may:
- Worsen claudication due to unopposed alpha stimulation
- Improve limb perfusion immediately
- Have minimal effect on peripheral resistance due to alpha-blockade
- Is absolutely contraindicated
Correct Answer: Have minimal effect on peripheral resistance due to alpha-blockade
Q39. Which of the following is a practical advantage of labetalol in hypertensive emergencies?
- Ability to titrate IV dose rapidly to desired BP
- Once-daily oral dosing only
- No need for monitoring during infusion
- Guaranteed renal protection in all patients
Correct Answer: Ability to titrate IV dose rapidly to desired BP
Q40. Labetalol should be used with caution in diabetic patients because it can:
- Enhance glucose tolerance
- Mask adrenergic warning signs of hypoglycemia like tachycardia
- Cause immediate hyperglycemia corrected by insulin
- Stimulate insulin release dramatically
Correct Answer: Mask adrenergic warning signs of hypoglycemia like tachycardia
Q41. Which adverse effect is commonly reported with labetalol therapy?
- Profound hyperkalemia
- Fatigue and dizziness
- Excessive hair growth
- Severe hypocalcemia
Correct Answer: Fatigue and dizziness
Q42. Which population requires dose adjustment or close monitoring when using labetalol due to reduced clearance?
- Patients with hepatic impairment
- Young healthy adults
- Patients with controlled asthma
- Patients with hyperthyroidism
Correct Answer: Patients with hepatic impairment
Q43. Labetalol’s alpha-blocking action primarily leads to which immediate vascular effect?
- Vasodilation of arterioles and decreased systemic vascular resistance
- Vasoconstriction of veins exclusively
- Increased systemic vascular resistance
- No change in vascular tone
Correct Answer: Vasodilation of arterioles and decreased systemic vascular resistance
Q44. Which statement regarding labetalol and lipid profile is most accurate?
- Labetalol dramatically lowers LDL cholesterol
- Labetalol has minimal clinically relevant effects on lipid metabolism compared with some older beta-blockers
- Labetalol causes marked hypertriglyceridemia in all patients
- Labetalol normalizes HDL in one week
Correct Answer: Labetalol has minimal clinically relevant effects on lipid metabolism compared with some older beta-blockers
Q45. For a patient with resistant hypertension who cannot tolerate ACE inhibitors, labetalol may be chosen because it:
- Raises renin levels dramatically
- Offers combined alpha and beta blockade to lower BP without ACE inhibition
- Is an ARB in disguise
- Acts as a diuretic
Correct Answer: Offers combined alpha and beta blockade to lower BP without ACE inhibition
Q46. Which adverse effect would suggest liver injury in a patient on labetalol?
- Jaundice and elevated transaminases
- Runny nose and sneezing
- Increased urinary frequency only
- Heightened sense of taste
Correct Answer: Jaundice and elevated transaminases
Q47. Labetalol dosing frequency for oral immediate-release formulations is typically:
- Once daily only
- Twice to three times daily depending on formulation
- Every 30 minutes
- Once weekly
Correct Answer: Twice to three times daily depending on formulation
Q48. In a patient with concurrent COPD and hypertension, labetalol should be:
- Automatically prescribed as first-line therapy
- Used with caution or avoided if bronchospasm risk is high due to nonselective beta blockade
- Given at triple doses to overcome bronchospasm
- Replaced with high-dose labetalol inhaler
Correct Answer: Used with caution or avoided if bronchospasm risk is high due to nonselective beta blockade
Q49. Which symptom would prompt immediate discontinuation and evaluation for serious adverse reaction while on labetalol?
- Mild headache
- New onset jaundice or dark urine
- Transient mild fatigue
- Occasional dry mouth
Correct Answer: New onset jaundice or dark urine
Q50. Which monitoring is important during IV labetalol infusion in hypertensive emergency?
- Serial blood pressure and cardiac monitoring
- Weekly chest X-ray only
- Monthly liver ultrasound only
- No monitoring required once infusion starts
Correct Answer: Serial blood pressure and cardiac monitoring
